Associate Director, US Field Analytics, Lung
Revolution Medicines
Summary
Reporting to the Director, Analytics and Insights, the Associate Director, US Field Analytics, Lung will serve as a key analytics partner to Revolution Medicines' field organization and Commercial leadership. This role combines strong hands-on analytical capabilities with strategic thinking and business partnership to improve field strategy, deployment, execution, and performance.
Job description
The Opportunity
Reporting to the Director, Analytics and Insights, the Associate Director, US Field Analytics, Lung will serve as a key analytics partner to Revolution Medicines' field organization and Commercial leadership. This role combines strong hands-on analytical capabilities with strategic thinking and business partnership to improve field strategy, deployment, execution, and performance.
Field Analytics & Strategy
- Lead analytics supporting the design, deployment, and ongoing optimization of RevMed lung-related field teams, including field force sizing and structure, territory design and alignment, resource allocation, and geographic opportunity assessment.
- Develop and evolve lung customer and account segmentation, targeting, and prioritization approaches to support effective field engagement.
- Own field lung KPIs, performance measurement frameworks, dashboards, scorecards, and reporting, providing leadership with visibility into performance and opportunities at the national, area, region, territory, account, and customer levels.
- Conduct advanced and ad hoc analyses to identify business drivers, risks, and opportunities and inform decisions related to field strategy, customer engagement, deployment, and execution.
- Support launch readiness and post-launch optimization.
Analytics & Technical Leadership
- Serve as a hands-on analytical leader, independently accessing, integrating, analyzing, and interpreting complex commercial datasets using analytics languages (SQL/Python), Excel, and business intelligence tools such as Power BI.
- Develop scalable analytical solutions and automate recurring analyses and reporting where appropriate.
- Partner with IS teams to define data and analytical requirements and ensure field analytics solutions are accurate, reliable, scalable, and fit for purpose.
- Establish and maintain strong standards for field analytics, including metric definitions, methodologies, data quality, documentation, and governance.
Business Partnership & Execution
- Serve as a trusted analytics thought partner to field leaders and senior Commercialization stakeholders.
- Proactively identify emerging business questions and opportunities.
- Partner cross-functionally with Field Leadership, Sales Operations, US Analytics & Insights, Marketing, Omnichannel, IS, and Medical functions.
- Drive adoption and effective use of targeting, dashboards, metrics, and analytical tools through ongoing partnership, communication, and training with field teams and leaders.
- Manage multiple concurrent initiatives and external analytics partners as needed, delivering high-quality work in a fast-paced and evolving environment.
Requirements
- Bachelor's degree in a quantitative or business-related discipline
- 8+ years of progressive experience in commercial analytics, field analytics, sales analytics, commercial operations, or a related function within pharmaceutical, biotechnology, or healthcare organizations
- Demonstrated experience with field strategy and analytics, including segmentation and targeting, territory design/alignment, field performance measurement, dashboards/reporting, and resource optimization
- Experience working with pharmaceutical commercial data, which may include claims, prescription, patient-level, account, distributor, specialty pharmacy, CRM, activity, and other third-party datasets
- Proficient in technical analytics tools, including SQL and/or Python, Excel, and BI tools
- Demonstrated ability to translate complex analyses into clear, actionable insights and recommendations for senior business leaders
- Strong business acumen, communication, and presentation skills, with demonstrated ability to influence across functions and levels of an organization
- Experience with alignment management software, and Veeva CRM preferred
- Oncology and/or oral oncolytic product experience preferred
- Experience supporting multiple field functions preferred
- Experience with field force sizing, territory optimization, geographic alignment, or resource allocation methodologies preferred
- Experience developing sophisticated customer/account segmentation and targeting approaches preferred
- Experience supporting commercial analytics from pre-launch through launch and post-launch optimization preferred
- Familiarity with specialty pharmacy, distribution, claims, account, and other oncology-relevant commercial datasets preferred
Benefits
- Competitive cash compensation
- Equity awards
- Health benefits
- Learning and development opportunities
Company overview
Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies for RAS-addicted cancers. The company is pioneering a new class of therapeutics that target oncogenic RAS mutations, which are among the most common drivers of human cancers. Revolution Medicines employs a unique approach to drug discovery, leveraging deep insights into RAS biology to develop small molecule inhibitors that can address previously undruggable targets. Their pipeline includes multiple clinical-stage candidates designed to inhibit various RAS pathway mutations, with a particular focus on KRAS G12C and other RAS variants. The company's scientific platform combines structural biology, medicinal chemistry, and computational approaches to design highly selective inhibitors. Revolution Medicines aims to transform cancer treatment by developing therapies that can overcome resistance mechanisms and provide durable clinical benefits for patients with RAS-driven malignancies. Their research represents a significant advancement in the field of targeted cancer therapy, addressing one of the most challenging areas in oncology drug development.